Your browser doesn't support javascript.
loading
Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.
Izikson, Ruvim; Leffell, David J; Bock, S Allan; Patriarca, Peter A; Post, Penny; Dunkle, Lisa M; Cox, Manon M J.
Afiliación
  • Izikson R; Protein Sciences Corporation, Meriden, CT, United States. Electronic address: rizikson@proteinsciences.com.
  • Leffell DJ; Yale University School of Medicine, New Haven, CT, United States.
  • Bock SA; University of Colorado Denver School of Medicine, Aurora, CO, United States.
  • Patriarca PA; Biologics Consulting Group, Inc., Bethesda, MD, United States.
  • Post P; Protein Sciences Corporation, Meriden, CT, United States.
  • Dunkle LM; Protein Sciences Corporation, Meriden, CT, United States. Electronic address: ldunkle@proteinsciences.com.
  • Cox MM; Protein Sciences Corporation, Meriden, CT, United States.
Vaccine ; 33(48): 6622-8, 2015 Nov 27.
Article en En | MEDLINE | ID: mdl-26529070

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipersensibilidad Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipersensibilidad Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2015 Tipo del documento: Article